Objective: To investigate appetite responses over 4 h to fructose beverages in obese men, relative to glucose and whey protein. Second, to investigate the effect of combining whey and fructose on postprandial appetite hormones. Design: Randomized, double-blind crossover study of four beverages (1.1 MJ) containing 50 g of whey, fructose, glucose or 25 g whey þ 25 g fructose. Blood samples and appetite ratings were collected for 4 h then a buffet meal was offered. Subjects: Twenty-eight obese men (age: 57.071.6 years, body mass index: 32.570.6 kg/m 2 ) Measurements: Plasma ghrelin (total), glucagon-like peptide-1 (GLP-1 7-36), cholecystokinin-8, glucose, insulin and appetite ratings were assessed at baseline and 30, 45, 60, 90, 120, 180, 240 min after beverages, followed by measurement of ad libitum energy intake. Results: Fructose produced lower glycaemia and insulinaemia compared to the glucose treatment (Po0.0001); whereas postprandial ghrelin, GLP-1 and cholecystokinin responses were similar after both treatments. Whey protein produced a prolonged (2-4 h) suppression of ghrelin (P ¼ 0.001) and elevation of GLP-1 (P ¼ 0.002) and cholecystokinin (P ¼ 0.003) that were reduced when combined with fructose, while glucose and insulin responses were similar. Energy intake after 4 h was independent of beverage type (glucose 4.770.2 MJ; fructose 4.970.3 MJ; whey 4.670.3 MJ; whey/fructose 4.870.3 MJ; P40.05). Conclusion: In obese men, fructose-and glucose-based beverages had similar effects on appetite and associated regulatory hormones, independent of the differing glycaemic and insulinaemic responses. The contrasting profile of plasma ghrelin, GLP-1 and cholecystokinin after whey protein consumption did not impact on ad libitum intake 4 h later and was attenuated when 50% of whey was replaced with fructose.
Background
Dietary manipulations that promote satiety (that is the absence of hunger during the inter-meal interval) have potential applications for the overweight population, such as improving adherence to restricted energy intake. Many appetite studies are performed in subjects with a normal body mass index (BMI) (20-25 kg/m 2 ); however, results derived from healthy weight subjects may not apply to the overweight population. For example, fasting and postprandial concentration of gut hormones involved in appetite regulation differ in overweight subjects compared to lean counterparts. [1] [2] [3] The impact of adiposity-dependent differences in appetite regulatory hormones on eating behaviour has not been well studied. Studies in lean subjects have shown that hunger ratings and subsequent food intake are reduced following consumption of dietary protein, compared to carbohydrate and fat. 4, 5 This may be explained by higher postprandial plasma concentration of the 'satiety' hormones glucagon-like peptide-1 (GLP-1) and cholecystokinin, observed in lean and obese men 1-3 h after ingestion of whey protein compared to glucose. 3, 6, 7 Additionally, ghrelin remains suppressed 3 h after dietary proteins relative to glucose 3, 6 and this may contribute to a reduction in hunger. Any impact of protein on these hormones over a period longer than 3 h has not been investigated.
Carbohydrates that produce low glycaemic and insulinaemic responses also seem to prolong satiety. 8 Fructose ingestion produces a small increase in blood glucose concentration, which reflects low-level hepatic metabolism of some fructose to glucose. It does not stimulate insulin secretion directly, although a small postprandial increase is observed due to a fructose-stimulated rise in the incretin GLP-1. 9 Despite this low glycaemic response, studies in lean subjects show that fructose and glucose consumption similarly affect subsequent energy intake. [10] [11] [12] Understanding the role of fructose on appetite regulation is important, particularly in overweight subjects, given the possible correlation between obesity prevalence and consumption of beverages sweetened with high-fructose corn syrup. 9, 13 Ghrelin has an inverse secretory pattern to insulin [14] [15] [16] and glucose, 17 suggesting that it may contribute to the apparent effects of glycaemic response on appetite. 8 We previously found that ghrelin remained moderately reduced 3 h after lactose (low glycaemic index) and whey-based liquid preloads relative to glucose and this predicted lower ad libitum energy intake in overweight men. 6 The duration of this ghrelin suppression and impact on hunger has not been investigated. We hypothesize that the effect of protein on ghrelin may be prolonged by combining protein with a carbohydrate that also produces a low glycaemic and insulinaemic response. Extending ghrelin suppression, and perhaps minimizing hunger ratings, for 4 h is relevant to inter-meal intervals in the free-living setting. The aim of this study was to compare postprandial glycaemia, appetite regulatory hormones (ghrelin, GLP-1 and cholecystokinin) and ad libitum energy intake after consumption of fructose-and glucose-based beverages in obese subjects. We also observed the effect of whey on these outcomes over 4 h when consumed alone and in combination with fructose.
Methods
This study was conducted at the Clinical Research Unit, Human Nutrition, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Adelaide, Australia, and was approved by the CSIRO Ethics Committee. All participants gave informed, written consent to participate.
Subjects
Healthy men aged 20-65 years were recruited by public advertisement. Inclusion criteria were a BMI425 kg/m 2 and a stable body weight for 3 months before the study. Exclusion criteria were illnesses or use of medications that affect glucose metabolism or appetite, a score of 410 on the eating restraint section of the validated Three Factor Eating questionnaire 18 and hypersensitivity to foods used in the study. Females were excluded to avoid the influence of menstrual cycle on eating behaviour.
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Thirty-three participants were eligible for participation. Five subjects withdrew before commencement (n ¼ 3 illness; n ¼ 1 personal reason, n ¼ 1 lost to contact). Twenty-eight subjects completed the study.
Experimental protocol
Subjects attended the Clinical Research Unit on four occasions with a 7-day interval between treatments. Subjects refrained from alcohol and strenuous exercise for 24 h before each visit and instructions were given to eat the standardized evening meal at the same time before each visit and fast thereafter (water permitted). The weight and height of subjects were measured upon arrival at the clinic (Mettler scales, AMZ14, A&D Mercury, Kinomoto, Japan). BMI was calculated as weight (kg) divided by height (m) 2 . An indwelling antecubital venous cannula was inserted and fasting blood samples were collected for measurement of gut hormones, insulin and glucose. After 15 min rest, subjects rated their appetite using a validated visual analogue scale (VAS) questionnaire 20 adapted to a sliding scale, computerized format (Northeast Data Corp. Slider ActiveX Custom Control (1.0) Charlotte, USA). 21 The questionnaire asked 'How hungry do you feel?', 'How satisfied do you feel', 'How full do you feel' and 'How much food would you like to eat now?' A 100 mm horizontal line was displayed below each question and opposing extremes of each feeling described at either end of the line (for example, 'I am not hungry at all' -'I have never been hungrier'). Subjects moved the cursor along the line using the mouse to indicate how they felt at that moment. In addition, palatability, taste, aftertaste and smell were assessed after consuming the beverages using a similar VAS. The beverages were served chilled (41C) 15 min after the baseline measurements in an opaque, closed container and consumed through a straw within 7 min. Treatments were given in a randomized, double-blind order. Subsequent blood samples and VAS responses were collected 30, 45, 60, 90, 120, 180 and 240 min after commencing the test drink. Subjects were allowed to read, watch television and talk with other participants (avoiding food-related conversation) during this time. Subjects could drink water and the volume of this was kept constant between study days. Cannulae were removed after the final blood sample and the buffet lunch was provided. Instructions were given to eat until satisfied and the foods were available for 30 min.
Dietary protocol
A standardized evening meal was given to subjects for consumption before study days (3.1 MJ; 38% of total energy from protein, 21% fat, 41% carbohydrate).
The beverages contained 50 g of the test ingredient (whey protein, fructose, glucose or a combination of 25 g of whey and 25 g of fructose), water and milk (1% fat) ( Table 1) . The milk contributed a small, equal amount of protein, fat and carbohydrate to all treatments. Beverages were matched for palatability and sweetness using a non-caloric, chocolateflavoured sweetener.
The ad libitum 'buffet' style lunch included meat sauce, tuna casserole, pasta and rice. Each subject was allocated large servings (600 g) of each food and this provided total of B12 MJ with 28% of total energy from protein, 29% from fat and 43% from carbohydrate. Foods were weighed to the nearest gram before and after lunch using digital scales. Subjects ate in a group of six to replicate the free-living setting. Energy and nutrient composition were calculated using Food Works 3.02 (Xyris Software, Highgate Hill, Australia) based on the Australian Food Composition Tables. 22 
Biochemistry
Blood was collected into chilled sodium fluoride/ethylenediamine tetraacetic acid (1 g/l) tubes for plasma insulin and glucose analysis. Aprotinin (500 KIU/1 ml blood; Trasylol, Bayer, Leverkusen Germany) was preloaded into chilled tubes for cholecystokinin and ghrelin analysis. Dipeptidyl peptidase-IV (DPP-IV) inhibitor (10 ml/ml blood; Linco, MO, USA) was added to chilled tubes for GLP-1 analysis. Blood samples were stored on ice and plasma was isolated within 30 min by centrifugation (10 min, 2000 g, 51C) (Beckman GS-6R Centrifuge, Fullerton, CA, USA). Aliquots were stored at À801C.
Commercially available radioimmunoassay kits were used to measure total ghrelin (Phoenix Pharmaceuticals, Belmont, CA, USA; CV 5.5%) and cholecystokinin-8 (Euria-diagnostica, Malmo, Sweden; CV 14%). Ethanol extraction was performed on plasma for cholecystokinin analysis according to the manufacturer's instructions. Active GLP-1 (7-36) was measured by fluorescence immunoassay (Linco; CV 8.0%). Plasma insulin was measured using an ELISA immunoassay kit (Mercodia, Uppsala, Sweden). Plasma glucose was determined using an enzymatic kit (Hoffman-LaRoche Diagnostics, Basel, Switzerland) and control sera on a Hitachi 902 Automatic Analyser (Roche Diagnostics, Basel, Switzerland). The homeostasis model assessment (HOMA) was used as a surrogate measure of insulin sensitivity (fasting insulin(mU/l) Â fasting glucose (mmol/l)/22.5). 23 
Statistics
Results are expressed as means7s.e.m. for 28 subjects. For analysis of the appetite questionnaire, the distance between the left end of the scale and each mark was measured (mm). Baseline values were subtracted from postprandial responses to normalize between-subject differences. Reliability analysis was performed (Cronbach's alpha) for the questions 'How hungry do you feel?', 'How satisfied do you feel', 'How full do you feel', 'How much food would you like to eat now?' to assess inter item correlation; that is, are the questions measuring the same construct. The reliability (a ¼ 0.047) improved by combining the questions 'How satisfied do you feel/How full do you feel?' (a ¼ 1.789), and separately combining 'How hungry do you feel/How much food would you like to eat now?' (a ¼ 0.554), confirmed by Pearson correlations (twotailed, Po0.01). The mean response to 'How hungry do you feel/How much food would you like to eat now?' and 'How satisfied do you feel/How full do you feel?' was calculated for each subject and used for subsequent analysis.
Analysis of variance (ANOVA) with repeated measures was used to determine the effect of time (min) and treatment and Bonferroni adjustments for multiple comparisons. HOMA was included as a covariate for ghrelin, 24 GLP-1, 25 insulin and glucose analysis. Tukey's post hoc tests were performed to compare group differences where ANOVA showed a significant main effect. Relationships between variables were examined using multiple linear regressions that adjusted for the repeated nature of the data. Statistical analysis was performed using SPSS 14.0 for WINDOWS (SPSS Inc., Chicago, USA). The study had 80% power (a ¼ 0.05) to detect a 20% change in energy intake at the buffet meal. Statistical significance was set at an a-level of Po0.05. ). Subjective ratings of palatability, taste, aftertaste and smell did not differ between treatments (data not shown) and all treatments were well tolerated.
Glucose and insulin
Plasma glucose response was highest after the glucose treatment compared to fructose, which was in turn higher than the whey and whey/fructose treatments (time by treatment interaction; Po0.0005; Figure 1a) . By the end of the sampling period (240 min), glucose concentration was lower after the glucose beverage (4.5670.07 mmol/l) compared to all other treatments (fructose; 4.9370.08, whey; 5.0170.06, whey/fructose 4.9170.09 mmol/l; Po0.01).
Fructose produced an insulin response that was significantly lower than all other treatments (time by treatment interactions; Po0.0005; Figure 1b ) and these differences resolved by 180 min.
Appetite hormones
The mean ghrelin nadir (that is lowest value of the mean) was similar after all treatments, however, it occurred later . Data are expressed as mean7s.e.m. and compared using repeated measures ANOVA with Tukey's post hoc test. Plasma glucose is significantly higher after glucose treatment compared to fructose, and the fructose response is greater than whey and whey/fructose (time by treatment interactions; Po0.0005). Plasma insulin is significantly lower after fructose compared to all other treatments (time by treatment interactions; Po0.0005). Plasma ghrelin after the whey treatment is different to the glucose treatment (time by treatment interactions; Po0.0005). Plasma GLP-1 is significantly higher after whey compared to all other treatments (time by treatment interactions; P ¼ 0.002). Cholecystokinin response to whey is greater than whey/fructose, which is also greater than the response to fructose and glucose (P ¼ 0.009). ANOVA, analysis of variance.
Acute appetite responses in obese males J Bowen et al after the whey and whey/fructose treatments (120 min) compared to the fructose and glucose beverages (60 min). At 180 min, ghrelin remained below baseline after whey and at 240 min it was significantly lower (14276 pmol/l) than the glucose treatment (16076 pmol/l) (time by treatment interaction, Po0.001; Figure 1c) .
All beverages produced an early increase in GLP-1, after which concentration rapidly declined following the glucose, fructose and whey/fructose treatments. The response to the whey treatment was significantly different to all other treatments; GLP-1 remained 18% above baseline at 120 min (time by treatment interaction, P ¼ 0.002; Figure 1d ).
There was a similar peak in cholecystokinin 30 min after all treatments. This was followed by a gradual decline for the glucose and fructose treatments. Whey produced a second increase such that concentration at 120 min was 16% greater compared to 90 min concentration (time by treatment interaction; P ¼ 0.009; Figure 1e ). Similarly, concentration 90 min after the whey/fructose treatment was 17% greater compared to the concentration at 60 min, (time by treatment interaction; P ¼ 0.009).
Energy intake and appetite ratings
There was no effect of treatment on macronutrient composition (data not shown) or total energy intake of foods consumed at the buffet lunch meal (glucose 47047274 kJ; fructose 49427280 kJ; whey 46237290 kJ; whey/fructose 47617277 kJ; P ¼ 0.121). Similarly the VAS questions (P ¼ 0.311-0.703; data not shown) were independent of treatment. The satisfied/full response showed a time by treatment interaction (P ¼ 0.046; Figure 2a ) whereby satisfaction/fullness was lower after fructose compared to whey. The hungry/how much food response remained independent of treatment (P ¼ 0.755; Figure 2b ).
There were significant correlations in energy intake between treatments (correlation coefficients varying from 0.56 to 0.76; Po0.01). In a linear regression, nadir ghrelin and insulin at 30 min were weakly related to energy intake (Po0.01 and P ¼ 0.06, respectively); together, they accounted for 10% of the variance in energy intake (Po0.01). Inclusion of HOMA as a covariate did not affect the statistical significance of time by treatment interactions.
Discussion
The first aim of this study was to compare the effects of fructose and glucose on appetite regulatory hormones and food intake in obese men. We found that both sugars produced similar plasma ghrelin, GLP-1 and cholecystokinin responses and ad libitum energy intake, despite marked differences in postprandial glycaemia and insulinaemia. Second, we have shown that ghrelin remains suppressed 4 h after whey protein relative to carbohydrate, although this (and the elevation of GLP-1 and cholecystokinin) was attenuated when combined with fructose. Despite these macronutrient-specific differences in appetite hormones, ad libitum food intake 4 h later was independent of treatment.
Fructose and glucose
Early studies in lean and overweight subjects reported lower energy intake after ingestion of fructose compared to glucose, [26] [27] [28] consistent with the proposed association between the glycaemic responses and appetite. 8 However, the present study in obese subjects, and others in lean subjects, [10] [11] [12] 29 show that energy intake was comparable 2-4 h after both sugars. The modest reduction in satisfaction/ fullness ratings observed after the fructose treatment may have been influenced by the faster gastric emptying of fructose, 30 although this did not affect subsequent intake.
The postprandial nadir and return to baseline concentration for the ghrelin was similar after consumption of fructose and glucose, reflecting previous findings after pure (100 g) Acute appetite responses in obese males J Bowen et al fructose and glucose loads (n ¼ 6). 31 Yet, when a fructose-rich beverage was consumed with a mixed breakfast meal the ghrelin nadir was smaller, relative to a glucose treatment. 32 The ghrelin response was not predicted by insulin, which contrasts the previously described inverse correlation between insulin and ghrelin. 15, 16 Interestingly, the ghrelin nadir and insulin at 30 min were weak predictors of energy intake. This suggests a possible relationship between greater insulin response to glucose, subsequent reduction in glucose below baseline concentration and increased energy intake. The moderate increase in ghrelin observed 240 min after the glucose treatment corresponded to a small reduction in plasma glucose concentration below fasting levels (180-240 min). Both increased ghrelin and low blood glucose concentrations are independently associated with hunger and meal initiation. 14, 33 Our results suggest these may be related. Future studies investigating the contribution of blood glucose to acute appetite responses may consider assessing postprandial changes in capillary, rather than venous, glucose concentration. This is recommended for assessment of glycaemic responses 34 because capillary glucose concentration is higher and less variable compared to venous samples. 35 The mean capillary concentration was þ 1.6 and þ 1.7 mmol/l higher than venous plasma at 30 and 45 min, respectively, after consumption of solid and liquid carbohydrate-rich preloads by lean adults. 34 This difference represents tissue uptake of glucose in the forearm and is most pronounced in insulin-sensitive, lean subjects. 36 Consequently, the peak concentration in plasma glucose at the tissues is also likely to be somewhat higher in these obese subjects. Capillary measurements (that is, fingerpick measurements) were not performed in the present study to minimize the impact of sample collection on subjective appetite ratings and energy intake. Further, previous findings indicated that this possible relationship between low glucose and an increase in ghrelin 3, 6 occurs at a concentration range (that is fasting) were there is a negligible difference between the two sampling sites. The rapid and similar increase in GLP-1, 0-60 min after both sugars suggests involvement of neural mechanisms to trigger an early GLP-1 release. Indeed, GLP-1 secreting L-cells in the proximal small intestine are not exposed to luminal contents. 37, 38 Interestingly, fructose does not stimulate another incretin, gastric inhibitory peptide as strongly as glucose. 39 While increased GLP-1 may promote satiation (that is meal termination), it is unlikely to contribute to satiety given the rapid decline after carbohydrate ingestion and short half-life of the hormone. 40 Indeed, GLP-1 did not predict food intake.
Whey, glucose and fructose Dietary proteins seem to have a coordinated effect on appetite hormones; GLP-1 and cholecystokinin are elevated in the early-mid postprandial phase and ghrelin remains suppressed during the late postprandial phase following liquid protein preloads relative to glucose. 3, 6 The present study extends these findings to show that the suppression of ghrelin persists 4 h after whey protein consumption. It would be valuable to determine if spontaneous meal requests/initiation are also delayed after consumption of protein and if this relates to the reduced ghrelin. Others have reported a similar pattern of increase in GLP-1 and cholecystokinin after a semisolid, high-protein mixed nutrient food relative to high-carbohydrate, and that difference persisted 180 min after the treatment. 7 The prolonged elevation in that study may have been due to the physical form of that preload. This effect of dietary protein on GLP-1 may be associated with a recent finding in rodents; the augmented active GLP-1 response after dietary protein ingestion was associated with a concomitant reduction in the activity of DPP-IV that cleaves and inactivates GLP-1.
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GLP-1 and cholecystokinin reduce gastric emptying 42, 43 and in turn, this influences postprandial appetite hormones 42, 44 and appetite responses. 45 Therefore, the effect of these hormones on gastric emptying after protein ingestion may contribute to the previously observed effect of protein on satiety, relative to carbohydrate. The length of the small intestine exposed to glucose affects the secretion of ghrelin and GLP-1 in human subjects; 46 ghrelin suppression and GLP-1 elevation were prolonged when 460 cm of small intestine was exposed to glucose. This may influence the hormone responses we have observed after dietary protein consumption. Protein requires longer than glucose to digest and absorb and therefore presumably reaches more distal regions of the small intestine. Whey protein is considered to be a 'rapidly' digested and absorbed protein 47 relative to other proteins, suggesting that the time course for postprandial changes in these hormones after ingestion of whole animal tissue proteins may be even longer than whey. Similarly, this relationship may influence ghrelin and GLP-1 responses after consumption of carbohydrates that require extensive digestion, compared to sugars that are rapidly absorbed in the proximal small intestine. Future studies should compare the effects of animal proteins, slowly digested carbohydrates and their combination on the time course of postprandial changes in appetite hormones, relationship to gastric empting and spontaneous meal requests. Whey is a comparatively potent insulinotropic dietary protein 48 and also stimulates incretin release, 48 necessary for insulin-mediated amino-acid uptake into cells. The substitution of 50% of the fructose with whey was associated with an increase in postprandial insulin to a level comparable with the whey treatment, but did not display the synergistic effects previously observed when a combined fructose and whey protein (50 g) treatment was consumed by type 2 diabetics, relative to fructose (25 g ) and whey alone (25 g). 49 The amount of protein required to prolong satiety remains unknown and has potential implications for the contribution of dietary composition on appetite sensations in the Acute appetite responses in obese males J Bowen et al free-living setting. The diminished cholecystokinin response after the combined whey/fructose beverage (32 g total protein) compared to the whey beverage (57 g total protein) suggests that it is the amount of protein ingested that may influence the magnitude of the postprandial response. Conversely, the GLP-1 response to the whey/fructose beverage indicates a possible threshold effect, such that a given amount of protein in absolute terms or possibly relative to fructose is required to prolonged GLP-1 concentration.
The similar energy intake after all treatments may reflect a sensation of emptiness owing to the liquid form of the preloads or the low energy content relative to the timing of the buffet meal ( þ 4 h). Both factors may have overwhelmed any influence of the preloads or subsequent appetite hormones. However, it is not known if subjects had reached 'maximum hunger' or whether preload consumption (independent of treatment) had an impact at the ad libitum meal. Inclusion of a noncaloric preload would indicate if ingestion of a 1 MJ preload affects consumption 4 h later. However, we were limited to the number of treatments that are feasible to implement in this crossover design before affecting participant burden and responsiveness.
The physical form of the preloads was also selected to minimize the influence of gastric emptying rate on appetite hormone responses 44 and because fructose is commonly consumed in beverages in the free-living setting. Given the early and prolonged increase in GLP-1 and CCK after the whey treatment, it is plausible that food intake may have been affected by treatment before the buffet lunch. Relating spontaneous meal requests to postprandial changes in these appetite hormones would provide further insight. Similarly, a relationship between dietary protein, postprandial changes in these appetite hormones and ad libitum intake may be observed after 4 h when preloads are higher in energy or solid. This study investigated responses in obese, healthy men. While there was no effect of insulin sensitivity on these outcomes, this may be due to the selection of non-diabetic subjects and therefore narrow range of variation in HOMA. Similar studies are also required in diabetic subjects and women.
In conclusion, fructose and glucose beverages have similar effects on appetite and associated regulatory hormones, independent of differing glycaemic and insulinaemic responses in obese men. The seemingly satiating profile of ghrelin, GLP-1 and cholecystokinin after whey protein consumption is attenuated by the substitution of some whey with fructose, although such macronutrient-specific differences in appetite hormones did not influence ad libitum energy intake after 4 h. The effect of combining other dietary proteins (that is animal muscle) with slowly digested/ absorbed carbohydrates on postprandial changes in appetite-related hormones and ad libitum energy intake warrants further investigation.
